| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |